Penn State Hershey Transplant Program Uses Assay to Monitor Cell-Mediated Immunity
Improvement Noted in Management of Transplant Recipients with Cancer<img src="http://feeds.foxbusiness.com/~r/foxbusiness/latest/~4/302334385" height="1" width="1"/><img src="http://feeds.foxnews.com/~r/foxnews/business/~4/302334701" height="1" width="1"/>
http://feeds.foxnews.com/~r/foxnews/business/~3/302334701/